Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if COCP is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
3 top institutions tracked
Sentiment: neutral
Last trade: buy 69 days ago
Red flags: 0
26 filers reported a long position in COCP for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $376.1K | 358.2K | +49.3% |
| RENAISSANCE TECHNOLOGIES LLC | $188.6K | 179.6K | +44.9% |
| TWO SIGMA INVESTMENTS, LP | $184.1K | 175.4K | New |
| GEODE CAPITAL MANAGEMENT, LLC | $80K | 76.2K | -15.5% |
| BlackRock, Inc. | $77.4K | 73.7K | Unchanged |
| CITADEL ADVISORS LLC | $47.4K | 45.1K | New |
| Neuberger Berman Group LLC | $33.5K | 31.9K | Unchanged |
| XTX Topco Ltd | $30.8K | 29.3K | -18.6% |
| JANE STREET GROUP, LLC | $27K | 25.8K | +102.7% |
| VANGUARD FIDUCIARY TRUST CO | $25.2K | 24K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.